The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism

Bone

Volumn 83, Issue , 2016, Pages 1-8

  Braithwaite, V S ^a,b   Prentice, A ^a,b   Darboe, M K ^b,c   Prentice, A M ^b,c   Moore, S E ^a,b,c  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b MRC Unit   (Gambia)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Africa; Bone health; Early life; FGF23; Iron status in pregnancy; Phosphate

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR 23; HEMOGLOBIN; IRON; PHOSPHATE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; MINERAL;

ADULT; AFRICA; ANEMIA; ARTICLE; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFANCY; INFANT; IRON DEFICIENCY; MINERAL METABOLISM; PHOSPHATE METABOLISM; PREGNANCY; PROTEIN BLOOD LEVEL; RISK FACTOR; ANTHROPOMETRY; BLOOD; CHILD; METABOLISM; PRESCHOOL CHILD; TIME FACTOR;

ANEMIA; ANTHROPOMETRY; BIOMARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROBLAST GROWTH FACTORS; HEMOGLOBINS; HUMANS; INFANT; IRON; MINERALS; PREGNANCY; TIME FACTORS;

EID: 84944463642     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.10.003     Document Type: Article

References (33)

1. Bergwitz C., Juppner H. FGF23 and syndromes of abnormal renal phosphate handling. Adv. Exp. Med. Biol. 2012, 728:41-64.
2. Wolf M. FGF23: fashion or physiology?. Clin. J. Am. Soc. Nephrol. 2010, 5:1727-1729.
3. Larsson T., Marsell R., Schipani E., Ohlsson C., Ljunggren O., Tenenhouse H.S., Juppner H., Jonsson K.B. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004, 145:3087-3094.
4. Zhang R., Lu Y., Ye L., Yuan B., Yu S., Qin C., Xie Y., Gao T., Drezner M.K., Bonewald L.F., Feng J.Q. Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J. Bone Miner. Res. 2011, 26:1047-1056.
5. Farrow E.G., Yu X., Summers L.J., Davis S.I., Fleet J.C., Allen M.R., Robling A.G., Stayrook K.R., Jideonwo V., Magers M.J., Garringer H.J., Vidal R., Chan R.J., Goodwin C.B., Hui S.L., Peacock M., White K.E. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:E1146-E1155.
6. Clinkenbeard E.L., Farrow E.G., Summers L.J., Cass T.A., Roberts J.L., Bayt C.A., Lahm T., Albrecht M., Allen M.R., Peacock M., White K.E. Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J. Bone Miner. Res. 2014, 29:361-369.
7. Braithwaite V., Jarjou L.M., Goldberg G.R., Jones H., Pettifor J.M., Prentice A. Follow-up study of Gambian children with rickets-like bone deformities and elevated plasma FGF23: possible aetiological factors. Bone 2012, 50:218-225.
8. Braithwaite V., Jarjou L.M.A., Goldberg G.R., Prentice A. Iron status and fibroblast growth factor-23 in Gambian children. Bone 2012, 50:1351-1356.
9. Braithwaite V., Jones K.S., Assar S., Schoenmakers I., Prentice A. Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children. Endocr Connect 2014, 3:1-10.
10. Braithwaite V., Prentice A.M., Doherty C., Prentice A. FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study. Int. J. Pediatr. Endocrinol. 2012, 2012:27.
11. Imel E.A., Peacock M., Gray A.K., Padgett L.R., Hui S.L., Econs M.J. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J. Clin. Endocrinol. Metab. 2011, 96.
12. Bozentowicz-Wikarek M., Kocelak P., Owczarek A., Olszanecka-Glinianowicz M., Mossakowska M., Skalska A., Wiecek A., Chudek J. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?. Clin. Biochem. 2015, 48:431-436.
13. The National Nutrition Agency (NaNA) The Medical Research Council The Gambia. Nationwide Survey on The Prevalence of Vitamin A and Iron Deficiency in Women and Children in The Gambia. Banjul 2001, (The Gambia).
14. Prentice A., Ceesay M., Nigdikar S., Allen S.J., Pettifor J.M. FGF23 is elevated in Gambian children with rickets. Bone 2008, 42:788-797.
15. Moore S.E., Fulford A.J., Darboe M.K., Jobarteh M.L., Jarjou L.M., Prentice A.M. A randomized trial to investigate the effects of pre-natal and infant nutritional supplementation on infant immune development in rural Gambia: the ENID trial: early nutrition and immune development. BMC Pregnancy Childbirth 2012, 12:107.
16. Organization W.H. WHO Anthro for Personal Computers: Software for Assessing Growth and Development of the World's Children 2011, (In. 3.2.2 ed).
17. Punnonen K., Irjala K., Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997, 89:1052-1057.
18. Grubb A.O. Cystatin C-Properties and Use as Diagnostic Marker. Adv Clin Chem 2001, 72-84. Elsevier, San Diego. H.E. Spiegel (Ed.).
19. Barth J., Fiddy J., Payne R. Adjustment of serum total calcium for albumin concentration: effects of non-linerarity and of regression differences between laboratories. Ann. Clin. Biochem. 1996, 33:55-58.
20. Lozoff B., Beard J., Connor J., Barbara F., Georgieff M., Schallert T. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr. Rev. 2006, 64:S34-S43. discussion S72-91.
21. Fatani T., Binjab A., Weiler H., Sharma A., Rodd C. Persistent elevation of fibroblast growth factor 23 concentrations in healthy appropriate-for-gestational-age preterm infants. J. Pediatr. Endocrinol. Metab. 2015, 28:825-832.
22. Prentice A.M., Moore S.E., Fulford A.J. Growth faltering in low-income countries. World Rev. Nutr. Diet. 2013, 106:90-99.
23. Kovar I., Mayne P., Barltrop D. Plasma alkaline phosphatase activity: a screening test for rickets in preterm neonates. Lancet 1982, 1:308-310.
24. Kirby B.J., Ma Y., Martin H.M., Buckle Favaro K.L., Karaplis A.C., Kovacs C.S. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone. J. Bone Miner. Res. 2013, 28:1987-2000.
25. Ohata Y., Yamazaki M., Kawai M., Tsugawa N., Tachikawa K., Koinuma T., Miyagawa K., Kimoto A., Nakayama M., Namba N., Yamamoto H., Okano T., Ozono K., Michigami T. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice. J. Bone Miner. Res. 2014, 29:1627-1638.
26. Khosravi A., Cutler C.M., Kelly M.H., Chang R., Royal R.E., Sherry R.M., Wodajo F.M., Fedarko N.S., Collins M.T. Determination of the elimination half-life of fibroblast growth factor-23. J. Clin. Endocrinol. Metab. 2007, 92:2374-2377.
27. Berndt T.J., Craig T.A., McCormick D.J., Lanske B., Sitara D., Razzaque M.S., Pragnell M., Bowe A.E., O'Brien S.P., Schiavi S.C., Kumar R. Biological activity of FGF-23 fragments. Pflugers Arch. 2007, 454:615-623.
28. Goetz R., Nakada Y., Hu M.C., Kurosu H., Wang L., Nakatani T., Shi M., Eliseenkova A.V., Razzaque M.S., Moe O.W., Kuro-o M., Mohammadi M. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:407-412.
29. Elsammak M., Attia A., Suleman M. Fibroblast growth factor 23 (FGF23) and hypophosphatemia in patients with COPD. ERJ 2011, 38:3581.
30. Drake K.A., Sauerbry M.J., Blohowiak S.E., Repyak K.S., Kling P.J. Iron deficiency and renal development in the newborn rat. Pediatr. Res. 2009, 66:619-624.
31. Braithwaite V., Jones K.S., Schoenmakers I., Silver M., Prentice A., Hennig B.J. Vitamin D binding protein genotype is associated with plasma 25OHD concentration in West African children. Bone 2015.
32. Prentice A. Vitamin D deficiency: a global perspective. Nutr. Rev. 2008, 66:S153-S164.
33. Organization W.H. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity 2011, World Health Organization, Geneva, Switzerland.